Treatment of abdominal striae distensae in Fitzpatrick skin types IV to V using a 1064‐nm picosecond laser with a fractionated microlens array

Background Striae distensae are atrophic dermal scars that can cause psychosocial distress among affected patients. Despite numerous available therapeutic modalities, no gold standard treatment has been established. Objective To evaluate the long‐term efficacy and safety of a fractional 1064‐nm pico...

Full description

Saved in:
Bibliographic Details
Published inLasers in surgery and medicine Vol. 54; no. 1; pp. 129 - 137
Main Authors Kaewkes, Arisa, Manuskiatti, Woraphong, Cembrano, Kathryn Anne, Wanitphakdeedecha, Rungsima
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.01.2022
Subjects
Online AccessGet full text
ISSN0196-8092
1096-9101
1096-9101
DOI10.1002/lsm.23471

Cover

Abstract Background Striae distensae are atrophic dermal scars that can cause psychosocial distress among affected patients. Despite numerous available therapeutic modalities, no gold standard treatment has been established. Objective To evaluate the long‐term efficacy and safety of a fractional 1064‐nm picosecond laser for the treatment of striae alba in individuals with dark skin types. Materials and Methods Twenty volunteers with Fitzpatrick skin types IV–V who presented with striae alba were enrolled. Subjects were treated with a fractional 1064‐nm picosecond laser for four sessions at 4‐week intervals. The skin texture, average melanin index (MI), and melanin variation score were assessed using Antera 3D® before treatment, at 1 month after the second treatment, and at 1, 3, and 6 months after the last treatment. Two independent investigators evaluated clinical improvement by comparing pretreatment and posttreatment photographs. The patient satisfaction rates were likewise assessed. Adverse effects were recorded during the entire study period. Results Significant improvement of skin texture was seen at 1 month after the final treatment (p < 0.001) and continuously improved until the 6‐month follow‐up visit (p = 0.003). The average MI significantly increased at 1 month after the final treatment (p < 0.001), whereas the melanin variation score decreased throughout the follow‐up period. Investigator assessment at the 6‐month follow‐up revealed that 90% of subjects had moderate to marked improvement of striae appearance. Only two of 20 subjects (10%) developed transient postinflammatory hyperpigmentation (PIH) after laser treatment. Conclusion Fractional picosecond 1064‐nm laser is effective and well‐tolerated for the treatment of striae alba in dark‐skinned individuals with a low incidence of PIH.
AbstractList Striae distensae are atrophic dermal scars that can cause psychosocial distress among affected patients. Despite numerous available therapeutic modalities, no gold standard treatment has been established.BACKGROUNDStriae distensae are atrophic dermal scars that can cause psychosocial distress among affected patients. Despite numerous available therapeutic modalities, no gold standard treatment has been established.To evaluate the long-term efficacy and safety of a fractional 1064-nm picosecond laser for the treatment of striae alba in individuals with dark skin types.OBJECTIVETo evaluate the long-term efficacy and safety of a fractional 1064-nm picosecond laser for the treatment of striae alba in individuals with dark skin types.Twenty volunteers with Fitzpatrick skin types IV-V who presented with striae alba were enrolled. Subjects were treated with a fractional 1064-nm picosecond laser for four sessions at 4-week intervals. The skin texture, average melanin index (MI), and melanin variation score were assessed using Antera 3D® before treatment, at 1 month after the second treatment, and at 1, 3, and 6 months after the last treatment. Two independent investigators evaluated clinical improvement by comparing pretreatment and posttreatment photographs. The patient satisfaction rates were likewise assessed. Adverse effects were recorded during the entire study period.MATERIALS AND METHODSTwenty volunteers with Fitzpatrick skin types IV-V who presented with striae alba were enrolled. Subjects were treated with a fractional 1064-nm picosecond laser for four sessions at 4-week intervals. The skin texture, average melanin index (MI), and melanin variation score were assessed using Antera 3D® before treatment, at 1 month after the second treatment, and at 1, 3, and 6 months after the last treatment. Two independent investigators evaluated clinical improvement by comparing pretreatment and posttreatment photographs. The patient satisfaction rates were likewise assessed. Adverse effects were recorded during the entire study period.Significant improvement of skin texture was seen at 1 month after the final treatment (p < 0.001) and continuously improved until the 6-month follow-up visit (p = 0.003). The average MI significantly increased at 1 month after the final treatment (p < 0.001), whereas the melanin variation score decreased throughout the follow-up period. Investigator assessment at the 6-month follow-up revealed that 90% of subjects had moderate to marked improvement of striae appearance. Only two of 20 subjects (10%) developed transient postinflammatory hyperpigmentation (PIH) after laser treatment.RESULTSSignificant improvement of skin texture was seen at 1 month after the final treatment (p < 0.001) and continuously improved until the 6-month follow-up visit (p = 0.003). The average MI significantly increased at 1 month after the final treatment (p < 0.001), whereas the melanin variation score decreased throughout the follow-up period. Investigator assessment at the 6-month follow-up revealed that 90% of subjects had moderate to marked improvement of striae appearance. Only two of 20 subjects (10%) developed transient postinflammatory hyperpigmentation (PIH) after laser treatment.Fractional picosecond 1064-nm laser is effective and well-tolerated for the treatment of striae alba in dark-skinned individuals with a low incidence of PIH.CONCLUSIONFractional picosecond 1064-nm laser is effective and well-tolerated for the treatment of striae alba in dark-skinned individuals with a low incidence of PIH.
Striae distensae are atrophic dermal scars that can cause psychosocial distress among affected patients. Despite numerous available therapeutic modalities, no gold standard treatment has been established. To evaluate the long-term efficacy and safety of a fractional 1064-nm picosecond laser for the treatment of striae alba in individuals with dark skin types. Twenty volunteers with Fitzpatrick skin types IV-V who presented with striae alba were enrolled. Subjects were treated with a fractional 1064-nm picosecond laser for four sessions at 4-week intervals. The skin texture, average melanin index (MI), and melanin variation score were assessed using Antera 3D® before treatment, at 1 month after the second treatment, and at 1, 3, and 6 months after the last treatment. Two independent investigators evaluated clinical improvement by comparing pretreatment and posttreatment photographs. The patient satisfaction rates were likewise assessed. Adverse effects were recorded during the entire study period. Significant improvement of skin texture was seen at 1 month after the final treatment (p < 0.001) and continuously improved until the 6-month follow-up visit (p = 0.003). The average MI significantly increased at 1 month after the final treatment (p < 0.001), whereas the melanin variation score decreased throughout the follow-up period. Investigator assessment at the 6-month follow-up revealed that 90% of subjects had moderate to marked improvement of striae appearance. Only two of 20 subjects (10%) developed transient postinflammatory hyperpigmentation (PIH) after laser treatment. Fractional picosecond 1064-nm laser is effective and well-tolerated for the treatment of striae alba in dark-skinned individuals with a low incidence of PIH.
BackgroundStriae distensae are atrophic dermal scars that can cause psychosocial distress among affected patients. Despite numerous available therapeutic modalities, no gold standard treatment has been established.ObjectiveTo evaluate the long‐term efficacy and safety of a fractional 1064‐nm picosecond laser for the treatment of striae alba in individuals with dark skin types.Materials and MethodsTwenty volunteers with Fitzpatrick skin types IV–V who presented with striae alba were enrolled. Subjects were treated with a fractional 1064‐nm picosecond laser for four sessions at 4‐week intervals. The skin texture, average melanin index (MI), and melanin variation score were assessed using Antera 3D® before treatment, at 1 month after the second treatment, and at 1, 3, and 6 months after the last treatment. Two independent investigators evaluated clinical improvement by comparing pretreatment and posttreatment photographs. The patient satisfaction rates were likewise assessed. Adverse effects were recorded during the entire study period.ResultsSignificant improvement of skin texture was seen at 1 month after the final treatment (p < 0.001) and continuously improved until the 6‐month follow‐up visit (p = 0.003). The average MI significantly increased at 1 month after the final treatment (p < 0.001), whereas the melanin variation score decreased throughout the follow‐up period. Investigator assessment at the 6‐month follow‐up revealed that 90% of subjects had moderate to marked improvement of striae appearance. Only two of 20 subjects (10%) developed transient postinflammatory hyperpigmentation (PIH) after laser treatment.ConclusionFractional picosecond 1064‐nm laser is effective and well‐tolerated for the treatment of striae alba in dark‐skinned individuals with a low incidence of PIH.
Background Striae distensae are atrophic dermal scars that can cause psychosocial distress among affected patients. Despite numerous available therapeutic modalities, no gold standard treatment has been established. Objective To evaluate the long‐term efficacy and safety of a fractional 1064‐nm picosecond laser for the treatment of striae alba in individuals with dark skin types. Materials and Methods Twenty volunteers with Fitzpatrick skin types IV–V who presented with striae alba were enrolled. Subjects were treated with a fractional 1064‐nm picosecond laser for four sessions at 4‐week intervals. The skin texture, average melanin index (MI), and melanin variation score were assessed using Antera 3D® before treatment, at 1 month after the second treatment, and at 1, 3, and 6 months after the last treatment. Two independent investigators evaluated clinical improvement by comparing pretreatment and posttreatment photographs. The patient satisfaction rates were likewise assessed. Adverse effects were recorded during the entire study period. Results Significant improvement of skin texture was seen at 1 month after the final treatment (p < 0.001) and continuously improved until the 6‐month follow‐up visit (p = 0.003). The average MI significantly increased at 1 month after the final treatment (p < 0.001), whereas the melanin variation score decreased throughout the follow‐up period. Investigator assessment at the 6‐month follow‐up revealed that 90% of subjects had moderate to marked improvement of striae appearance. Only two of 20 subjects (10%) developed transient postinflammatory hyperpigmentation (PIH) after laser treatment. Conclusion Fractional picosecond 1064‐nm laser is effective and well‐tolerated for the treatment of striae alba in dark‐skinned individuals with a low incidence of PIH.
Author Wanitphakdeedecha, Rungsima
Kaewkes, Arisa
Manuskiatti, Woraphong
Cembrano, Kathryn Anne
Author_xml – sequence: 1
  givenname: Arisa
  surname: Kaewkes
  fullname: Kaewkes, Arisa
  organization: Mahidol University
– sequence: 2
  givenname: Woraphong
  orcidid: 0000-0001-8393-7963
  surname: Manuskiatti
  fullname: Manuskiatti, Woraphong
  email: woraphong.man@mahidol.edu
  organization: Mahidol University
– sequence: 3
  givenname: Kathryn Anne
  surname: Cembrano
  fullname: Cembrano, Kathryn Anne
  organization: Mahidol University
– sequence: 4
  givenname: Rungsima
  orcidid: 0000-0002-3926-2193
  surname: Wanitphakdeedecha
  fullname: Wanitphakdeedecha, Rungsima
  organization: Mahidol University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34420222$$D View this record in MEDLINE/PubMed
BookMark eNp1kcFu1DAURS1URKeFBT-ALLGBxbTPduIkS1RRqDSIBaVb603yDG4Te7AdVcOKT-g38iW4zHRTwcpP9rn3yfcesQMfPDH2UsCJAJCnY5pOpKoa8YQtBHR62QkQB2wBoswtdPKQHaV0DQBKQvOMHaqqkiClXLC7y0iYJ_KZB8txPYTJeRx5ytEh8cGlTD6VyXl-7vLPDZaH_oanm3KRtxtK_OKK58Cv-Jyc_8aRC9DV7193fuIb14dEffADHzFR5Lcufy-EjdhnFzxmGvjk-hjGsoRjjLh9zp5aHBO92J_H7Ov5-8uzj8vV5w8XZ-9Wy17VSixrhWtQNAgaqrapNNmmxUY1AoVC3Q0ATVdVQlhbg6rR6tp2Ha2VkKq1g27UMXuz893E8GOmlM3kUk_jiJ7CnIystdJdA1Vb0NeP0Oswx5JSobSETmkNslCv9tS8nmgwm-gmjFvzkHUBTndA-W9KkazpXcb7HHJENxoB5r5NU9o0f9ssirePFA-m_2L37rdupO3_QbP68mmn-AMt4q7S
CitedBy_id crossref_primary_10_1002_lsm_23584
crossref_primary_10_1007_s10103_022_03704_y
crossref_primary_10_1111_jocd_15458
crossref_primary_10_25289_ML_2022_11_3_125
crossref_primary_10_1002_lsm_23675
crossref_primary_10_2147_CCID_S450081
crossref_primary_10_2147_CCID_S379904
crossref_primary_10_1097_DSS_0000000000004111
Cites_doi 10.1007/s40257-016-0182-8
10.1016/j.asj.2005.09.004
10.5021/ad.2011.23.4.481
10.1002/lsm.23052
10.1080/14764172.2019.1710536
10.1046/j.1365-2133.1998.02257.x
10.1002/lsm.23151
10.1002/lsm.22458
10.1001/archderm.134.2.167
10.1111/srt.12186
10.1001/jamadermatol.2014.3045
10.1038/jid.2010.155
10.1097/DSS.0000000000001555
10.1016/j.jaad.2017.02.048
10.1007/s10103-019-02906-1
10.1002/lsm.23382
10.1002/lsm.22752
10.1016/j.jaad.2015.12.010
10.1111/dsu.12030
10.1080/09546634.2018.1506078
10.1111/bjd.12681
10.1002/lsm.23177
10.1111/bjd.15895
10.1002/lsm.23401
10.1111/jdv.13223
10.1097/DSS.0000000000001669
10.1002/lsm.22577
10.1002/lsm.22734
10.1002/lsm.22105
10.1097/DSS.0000000000002081
ContentType Journal Article
Copyright 2021 Wiley Periodicals LLC
2021 Wiley Periodicals LLC.
2022 Wiley Periodicals LLC
Copyright_xml – notice: 2021 Wiley Periodicals LLC
– notice: 2021 Wiley Periodicals LLC.
– notice: 2022 Wiley Periodicals LLC
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
8FD
FR3
K9.
M7Z
P64
7X8
DOI 10.1002/lsm.23471
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biochemistry Abstracts 1
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Biochemistry Abstracts 1
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Biochemistry Abstracts 1

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Physics
EISSN 1096-9101
EndPage 137
ExternalDocumentID 34420222
10_1002_lsm_23471
LSM23471
Genre caseStudy
Case Reports
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AAQQT
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HJTMK
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XPP
XV2
ZGI
ZZTAW
~IA
~WT
AAYXX
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
K9.
M7Z
P64
7X8
ID FETCH-LOGICAL-c3531-53ab03ed1ed48746ef78a7371a13a69d00794411ff5035af65f99eb31238fd673
IEDL.DBID DR2
ISSN 0196-8092
1096-9101
IngestDate Fri Jul 11 06:17:05 EDT 2025
Fri Jul 25 12:20:11 EDT 2025
Wed Feb 19 02:26:58 EST 2025
Tue Jul 01 02:22:32 EDT 2025
Thu Apr 24 23:04:50 EDT 2025
Wed Jan 22 16:27:38 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Fitzpatrick skin type IV
Fitzpatrick skin type V
striae alba
dark-skinned type
striae distensae
stretch marks
1064 nm
fractional picosecond laser
microlens array
Language English
License 2021 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3531-53ab03ed1ed48746ef78a7371a13a69d00794411ff5035af65f99eb31238fd673
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ORCID 0000-0001-8393-7963
0000-0002-3926-2193
PMID 34420222
PQID 2620936602
PQPubID 1016352
PageCount 9
ParticipantIDs proquest_miscellaneous_2563697048
proquest_journals_2620936602
pubmed_primary_34420222
crossref_citationtrail_10_1002_lsm_23471
crossref_primary_10_1002_lsm_23471
wiley_primary_10_1002_lsm_23471_LSM23471
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2022
2022-01-00
20220101
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – month: 01
  year: 2022
  text: January 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Lasers in surgery and medicine
PublicationTitleAlternate Lasers Surg Med
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2019; 30
2017; 49
2013; 45
2016; 30
2016; 74
2020; 35
2014; 170
1998; 138
2016; 17
2018; 44
1998; 134
2005; 25
2015; 151
2013; 39
2020; 52
2021
2020
2017; 77
2018; 178
2019; 45
2015; 21
2010; 130
2020; 46
2011; 23
2020; 22
2018; 50
2016; 48
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
Manuskiatti W (e_1_2_7_15_1) 2020
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_22_1
e_1_2_7_21_1
e_1_2_7_20_1
References_xml – volume: 35
  start-page: 949
  issue: 4
  year: 2020
  end-page: 56
  article-title: Split‐face comparison of the picosecond 1064‐nm Nd:YAG laser using a microlens array and the quasi‐long‐pulsed 1064‐nm Nd:YAG laser for treatment of photoaging facial wrinkles and pores in Asians
  publication-title: Lasers Med Sci
– volume: 74
  start-page: 931
  issue: 5
  year: 2016
  end-page: 6
  article-title: Safety of a picosecond laser with diffractive lens array (DLA) in the treatment of Fitzpatrick skin types IV to VI: a retrospective review
  publication-title: J Am Acad Dermatol
– volume: 48
  start-page: 245
  issue: 3
  year: 2016
  end-page: 53
  article-title: Fractionated bipolar radiofrequency and bipolar radiofrequency potentiated by infrared light for treating striae: a prospective randomized, comparative trial with objective evaluation
  publication-title: Lasers Surg Med
– volume: 17
  start-page: 239
  issue: 3
  year: 2016
  end-page: 56
  article-title: Laser and light treatments for striae distensae: a comprehensive review of the literature
  publication-title: Am J Clin Dermatol
– volume: 178
  start-page: 749
  issue: 3
  year: 2018
  end-page: 60
  article-title: Severe disruption and disorganization of dermal collagen fibrils in early striae gravidarum
  publication-title: Br J Dermatol
– volume: 49
  start-page: 40
  issue: 1
  year: 2017
  end-page: 4
  article-title: Safety and efficacy of a novel diffractive lens array using a picosecond 755 nm alexandrite laser for treatment of wrinkles
  publication-title: Lasers Surg Med
– volume: 49
  start-page: 796
  issue: 9
  year: 2017
  end-page: 802
  article-title: Treatment of acne scarring with a novel fractionated, dual‐wavelength, picosecond‐domain laser incorporating a novel holographic beam‐splitter
  publication-title: Lasers Surg Med
– volume: 50
  start-page: 37
  issue: 1
  year: 2018
  end-page: 44
  article-title: A comparative study with a 755 nm picosecond alexandrite laser with a diffractive lens array and a 532 nm/1064 nm Nd:YAG with a holographic optic
  publication-title: Lasers Surg Med
– volume: 30
  start-page: 294
  issue: 3
  year: 2019
  end-page: 302
  article-title: The use of energy devices in the treatment of striae: a systematic literature review
  publication-title: J Dermatolog Treat
– volume: 23
  start-page: 481
  issue: 4
  year: 2011
  end-page: 9
  article-title: Treatment of striae distensae with nonablative fractional laser versus ablative CO fractional laser: a randomized controlled trial
  publication-title: Ann Dermatol
– year: 2021
  article-title: Picosecond laser treatment of striae distensae: in vivo evaluation of results by 3D analysis, reflectance confocal microscopy, and patient's satisfaction
  publication-title: Lasers Surg Med
– volume: 138
  start-page: 931
  issue: 6
  year: 1998
  end-page: 7
  article-title: Fibrillin microfibrils are reduced in skin exhibiting striae distensae
  publication-title: Br J Dermatol
– year: 2020
  article-title: Objective and long‐term evaluation of the efficacy and safety of a 1064‐nm picosecond laser with fractionated microlens array for the treatment of atrophic acne scar in Asians
  publication-title: Lasers Surg Med
– volume: 45
  start-page: 81
  issue: 2
  year: 2013
  end-page: 8
  article-title: Transepidermal retinoic acid delivery using ablative fractional radiofrequency associated with acoustic pressure ultrasound for stretch marks treatment
  publication-title: Lasers Surg Med
– volume: 45
  start-page: 195
  issue: 2
  year: 2019
  end-page: 202
  article-title: Noninvasive atrophic acne scar treatment in Asians with a 755‐nm picosecond laser using a diffractive optic lens—a retrospective photographic review
  publication-title: Dermatol Surg
– volume: 25
  start-page: 593
  issue: 6
  year: 2005
  end-page: 600
  article-title: Skin biopsy analysis reveals predisposition to stretch mark formation
  publication-title: Aesthet Surg J
– volume: 44
  start-page: 1311
  issue: 10
  year: 2018
  end-page: 6
  article-title: A comparison study of the nonablative fractional 1565‐nm Er: glass and the picosecond fractional 1064/532‐nm Nd:YAG lasers in the treatment of striae alba: a split body double‐blinded trial
  publication-title: Dermatol Surg
– volume: 151
  start-page: 278
  issue: 3
  year: 2015
  end-page: 84
  article-title: Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring
  publication-title: JAMA Dermatol
– volume: 52
  start-page: 176
  issue: 2
  year: 2020
  end-page: 81
  article-title: Evaluation of the safety and efficacy of a picosecond alexandrite laser with DLA for acne scars in Chinese patients
  publication-title: Lasers Surg Med
– volume: 52
  start-page: 389
  issue: 5
  year: 2020
  end-page: 95
  article-title: Efficacy and safety of ablative resurfacing with a high‐energy 1,064 Nd‐YAG picosecond‐domain laser for the treatment of facial acne scars in Asians
  publication-title: Lasers Surg Med
– volume: 52
  start-page: 166
  issue: 2
  year: 2020
  end-page: 75
  article-title: Comparison between topical recombinant human epidermal growth factor and Aloe vera gel in combination with ablative fractional carbon dioxide laser as treatment for striae alba: a randomized double‐blind trial
  publication-title: Lasers Surg Med
– volume: 21
  start-page: 254
  issue: 2
  year: 2015
  end-page: 8
  article-title: Biophysical properties of striae distensae evaluated in vivo using non‐invasive assays
  publication-title: Skin Res Technol
– volume: 130
  start-page: 2396
  issue: 10
  year: 2010
  end-page: 406
  article-title: Aldosterone and mineralocorticoid receptor antagonists modulate elastin and collagen deposition in human skin
  publication-title: J Invest Dermatol
– year: 2021
  article-title: Fractional 1064 nm picosecond laser in treatment of melasma and skin rejuvenation in Asians, a prospective study
  publication-title: Lasers Surg Med
– volume: 39
  start-page: 111
  issue: 1 Pt 1
  year: 2013
  end-page: 20
  article-title: Comparison of fractional erbium‐doped yttrium aluminum garnet and carbon dioxide lasers in resurfacing of atrophic acne scars in Asians
  publication-title: Dermatol Surg
– volume: 170
  start-page: 527
  issue: 3
  year: 2014
  end-page: 47
  article-title: Striae distensae: a comprehensive review and evidence‐based evaluation of prophylaxis and treatment
  publication-title: Br J Dermatol
– volume: 22
  start-page: 43
  issue: 1
  year: 2020
  end-page: 7
  article-title: Histology of ex vivo skin after treatment with fractionated picosecond Nd:YAG laser in high and low‐energy settings
  publication-title: J Cosmet Laser Ther
– volume: 30
  start-page: 211
  issue: 2
  year: 2016
  end-page: 22
  article-title: Topical management of striae distensae (stretch marks): prevention and therapy of striae rubrae and albae
  publication-title: J Eur Acad Dermatol Venereol
– volume: 77
  start-page: 559
  issue: 3
  year: 2017
  end-page: 68
  article-title: Therapeutic targets in the management of striae distensae: a systematic review
  publication-title: J Am Acad Dermatol
– volume: 134
  start-page: 167
  issue: 2
  year: 1998
  end-page: 71
  article-title: Comparison of responses of tattoos to picosecond and nanosecond Q‐switched neodymium:YAG lasers
  publication-title: Arch Dermatol
– volume: 46
  start-page: 459
  issue: 4
  year: 2020
  end-page: 64
  article-title: Microneedling treatment of striae distensae in light and dark skin with long‐term follow‐up
  publication-title: Dermatol Surg
– ident: e_1_2_7_3_1
  doi: 10.1007/s40257-016-0182-8
– ident: e_1_2_7_7_1
  doi: 10.1016/j.asj.2005.09.004
– ident: e_1_2_7_23_1
  doi: 10.5021/ad.2011.23.4.481
– ident: e_1_2_7_24_1
  doi: 10.1002/lsm.23052
– ident: e_1_2_7_26_1
  doi: 10.1080/14764172.2019.1710536
– ident: e_1_2_7_4_1
  doi: 10.1046/j.1365-2133.1998.02257.x
– ident: e_1_2_7_17_1
  doi: 10.1002/lsm.23151
– ident: e_1_2_7_32_1
  doi: 10.1002/lsm.22458
– ident: e_1_2_7_11_1
  doi: 10.1001/archderm.134.2.167
– ident: e_1_2_7_8_1
  doi: 10.1111/srt.12186
– ident: e_1_2_7_13_1
  doi: 10.1001/jamadermatol.2014.3045
– ident: e_1_2_7_5_1
  doi: 10.1038/jid.2010.155
– ident: e_1_2_7_22_1
  doi: 10.1097/DSS.0000000000001555
– ident: e_1_2_7_10_1
  doi: 10.1016/j.jaad.2017.02.048
– ident: e_1_2_7_20_1
  doi: 10.1007/s10103-019-02906-1
– ident: e_1_2_7_16_1
  doi: 10.1002/lsm.23382
– ident: e_1_2_7_27_1
  doi: 10.1002/lsm.22752
– ident: e_1_2_7_28_1
  doi: 10.1016/j.jaad.2015.12.010
– ident: e_1_2_7_25_1
  doi: 10.1111/dsu.12030
– ident: e_1_2_7_30_1
  doi: 10.1080/09546634.2018.1506078
– ident: e_1_2_7_2_1
  doi: 10.1111/bjd.12681
– ident: e_1_2_7_18_1
  doi: 10.1002/lsm.23177
– ident: e_1_2_7_9_1
  doi: 10.1111/bjd.15895
– ident: e_1_2_7_21_1
  doi: 10.1002/lsm.23401
– year: 2020
  ident: e_1_2_7_15_1
  article-title: Objective and long‐term evaluation of the efficacy and safety of a 1064‐nm picosecond laser with fractionated microlens array for the treatment of atrophic acne scar in Asians
  publication-title: Lasers Surg Med
– ident: e_1_2_7_6_1
  doi: 10.1111/jdv.13223
– ident: e_1_2_7_14_1
  doi: 10.1097/DSS.0000000000001669
– ident: e_1_2_7_19_1
  doi: 10.1002/lsm.22577
– ident: e_1_2_7_12_1
  doi: 10.1002/lsm.22734
– ident: e_1_2_7_31_1
  doi: 10.1002/lsm.22105
– ident: e_1_2_7_29_1
  doi: 10.1097/DSS.0000000000002081
SSID ssj0003207
Score 2.4192562
Snippet Background Striae distensae are atrophic dermal scars that can cause psychosocial distress among affected patients. Despite numerous available therapeutic...
Striae distensae are atrophic dermal scars that can cause psychosocial distress among affected patients. Despite numerous available therapeutic modalities, no...
BackgroundStriae distensae are atrophic dermal scars that can cause psychosocial distress among affected patients. Despite numerous available therapeutic...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 129
SubjectTerms 1064 nm
Cicatrix - etiology
Cicatrix - pathology
dark‐skinned type
Evaluation
Fitzpatrick skin type IV
Fitzpatrick skin type V
fractional picosecond laser
Humans
Hyperpigmentation
Hyperpigmentation - etiology
Lasers
Lasers, Solid-State - therapeutic use
Melanin
microlens array
Microlenses
Patient Satisfaction
Patients
Scars
Skin
stretch marks
striae alba
striae distensae
Striae Distensae - surgery
Texture
Treatment Outcome
Title Treatment of abdominal striae distensae in Fitzpatrick skin types IV to V using a 1064‐nm picosecond laser with a fractionated microlens array
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Flsm.23471
https://www.ncbi.nlm.nih.gov/pubmed/34420222
https://www.proquest.com/docview/2620936602
https://www.proquest.com/docview/2563697048
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqSkhw4FFeCwUNiAOXbBPbcWJxQsCqIMoB2qoHpMiObbTabrJKsgd64if0N_JLGDublPKQEDcrmcSOM2PPjGe-IeSZyRRVzOWRYcJFPNEykmWsI4O2QZ5aS5XxJ7oHH8T-EX93kp5skRdDLkyPDzE63LxkhPXaC7jS7d4FaOhpu5xSxkP-eMKEx81__fECOorRIVXaA-5KOqAKxXRvfPLyXvSbgnlZXw0bzuwG-TwMtY8zWUzXnZ6WZ7-gOP7nt9wk1zeKKLzsOecW2bLVDrn2EzzhDrkSwkPL9jY5Pxzi0aF2oLSpQy0wCEU_LBjPK1WLrXkFs3l3tgrA_wtoF3jBe3lbeHsMXQ3H4APtv4ACNBL592_n1RJWcx80j3a5AVTlbQPeN4wUrumTLlAbNrD0gYO4Q7agmkZ9vUOOZm8OX-1Hm1oOUclQzKOUKR0zaxJr0ETiwrosVxnLEpUwJaRBVUWiZpY4l8YsVU6kTko09HFjzZ0RGbtLtqu6svcJlKWwpcmNKh3lpZBa5lzlQnOe6dwwNSHPh79alBugc19v47ToIZppgdNdhOmekKcj6apH9_gT0e7AGsVGwNvC4_hLJkRMJ-TJeBtF05-3qMrWa6RJBRMywzVyQu71LDX2wjin3tbGwQbG-Hv3xftPB6Hx4N9JH5Kr_u29q2iXbHfN2j5C5anTj4OU_ADaEhcY
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgQcCpRHFwoYxIFLtontOLHEBSFWW9jtAbZVLyhy_ECr7SarJHugJ35CfyO_hLGzSSkPCXGLkonsODP2N-OZzwi91Ikkkto00JTbgEW5CIQK80CDb5DGxhCp3Y7u9IiPj9n70_h0C73uamFafog-4OYsw8_XzsBdQPrgkjX0rF4OCWWugPya359zkOjjJXkUJV2xtKPcFaTjFQrJQf_q1dXoN4h5FbH6JWd0G33uOttmmiyG6yYfqvNfeBz_92vuoJ0NFsVvWuW5i7ZMsYtu_cRQuIuu-wxRVd9DF7MuJR2XFstcl_44MOzP_TBYO3UpariaF3g0b85Xnvt_gesF3HCB3hofnuCmxCfY5dp_wRKDn8i-f7solng1d3nz4JprDGjeVNiFh0HCVm3dBQBijZcudxAWyRrLqpJf76Pj0bvZ23GwOc4hUBQsPYipzENqdGQ0eEmMG5ukMqFJJCMqudCAVgSAs8jaOKSxtDy2QoCvD2trajVP6AO0XZSF2UNYKW6UTrVUljDFRS5SJlOeM5bkqaZygF51vzVTG65zd-TGWdayNJMMhjvzwz1AL3rRVUvw8Seh_U43so2N15mj8heU85AM0PP-MVin23KRhSnXIBNzykUC0-QAPWx1qm-FMkacuw2d9Zrx9-azyaepv3j076LP0I3xbDrJJodHHx6jm66lNnK0j7abam2eAJZq8qfeZH4AOugbNg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRSA4UCivhQIGceCS7SZ2nFg9IWDVQlshaKsekCLHD7TabrJKsgd64if0N_aXdOxsUspDQtyiZCI7zoznm_H4M8ArnchIUpsGmnIbsDAXgVCjPNAYG6SxMZHUbkV3b59vH7IPx_HxCmx1e2Fafog-4eYsw8_XzsDn2m5ekoae1LNhRJnbP36NcXSTDhF9vuSOolG3V9ox7oqooxUaRZv9q1ed0W8I8ypg9R5nvAZfu762hSbT4aLJh-r0FxrH__yYO3B7iUTJm1Z17sKKKdbh1k_8hOtw3deHqvoenB10BemktETmuvSHgRF_6och2ilLUePVpCDjSXM698z_U1JP8YZL89Zk54g0JTkirtL-G5EEo0R2_uOsmJH5xFXNY2CuCWJ5UxGXHEYJW7W7LhAOazJzlYPoImsiq0p-vw-H4_cHb7eD5WEOgaJo50FMZT6iRodGY4zEuLFJKhOahDKkkguNWEUgNAutjUc0lpbHVgiM9NGzplbzhD6A1aIszCMgSnGjdKqlshFTXOQiZTLlOWNJnmoqB_C6-6uZWjKduwM3TrKWoznKcLgzP9wDeNmLzlt6jz8JbXSqkS0tvM4ckb-gHBVvAC_6x2ibbsFFFqZcoEzMKRcJTpIDeNiqVN8KZSxywTZ21ivG35vPdr_s-YvH_y76HG58ejfOdnf2Pz6Bm66hNm20AatNtTBPEUg1-TNvMBfb-Rnl
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+abdominal+striae+distensae+in+Fitzpatrick+skin+types+IV+to+V+using+a+1064-nm+picosecond+laser+with+a+fractionated+microlens+array&rft.jtitle=Lasers+in+surgery+and+medicine&rft.au=Kaewkes%2C+Arisa&rft.au=Manuskiatti%2C+Woraphong&rft.au=Cembrano%2C+Kathryn+Anne&rft.au=Wanitphakdeedecha%2C+Rungsima&rft.date=2022-01-01&rft.eissn=1096-9101&rft.volume=54&rft.issue=1&rft.spage=129&rft_id=info:doi/10.1002%2Flsm.23471&rft_id=info%3Apmid%2F34420222&rft.externalDocID=34420222
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0196-8092&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0196-8092&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0196-8092&client=summon